Evidence map›Paper›PMID 16365147›Full record

ArticleThe Journal of experimental medicine2005

E47 is required for V(D)J recombinase activity in common lymphoid progenitors.

Lisa Borghesi, Jennifer Aites, Shakira Nelson, Preslav Lefterov, Pamela James, Rachel Gerstein

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of experimental medicine, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 85 citations in OpenAlex.

  1. The Function of E2A in B-Cell Development.Advances in experimental medicine and biology · 2024
    Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. MIST1, an Inductive Signal for Salivary Amylase in Mesenchymal Stem Cells.International journal of molecular sciences · 2019
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. B cell biology: an overview.Current allergy and asthma reports · 2014
    Review
  16. The prenatal origins of cancer.Nature reviews. Cancer · 2014
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lisa BorghesiDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA. borghesi@pitt.edu
Jennifer Aites
Shakira Nelson
Preslav Lefterov
Pamela James
Rachel Gerstein
University of Pittsburgh · USUniversity of Massachusetts Chan Medical School · US

Funding

REGULATION OF V(D)J RECOMBINATION IN B CELL DEVELOPMENTR01AI043534 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GERSTEIN, RACHEL M. · 2000 to 2011
$3.1M
Regulation of V(D)J recombination in B cell developmentR56AI043534 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GERSTEIN, RACHEL M. · 2005 to 2005
$357k
NIAID NIH HHS AI043534NIAID NIH HHS R01 AI043534NIAID NIH HHS R56 AI043534
6 · The paper itself

Abstract

Common lymphoid progenitors (CLPs) are the first bone marrow precursors in which V(D)J recombinase activity is up-regulated. Here, we show that loss of the transcription factor E47 produces a reduced CLP population that lacks V(D)J recombinase activity and D-J(H) rearrangements in vivo. Apart from a profound arrest before the pro-B cell stage, other downstream lymphoid progeny of CLPs are still intact in these mice albeit at reduced numbers. In contrast to the inhibition of recombinase activity in early B lineage precursors in E47-deficient animals, loss of either E47 or its cis-acting target Erag (enhancer of rag transcription) has little effect on recombinase activity in thymic T lineage precursors. Taken together, this work defines a role for E47 in regulating lineage progression at the CLP stage in vivo and describes the first transcription factor required for lineage-specific recombinase activity.

Indexed as

Gene Expression Regulation, EnzymologicAnimalsB-LymphocytesCell LineageDNA PrimersFlow CytometryGene Rearrangement, B-LymphocyteHematopoietic Stem CellsHomeodomain ProteinsMiceMice, TransgenicPolymerase Chain ReactionTCF Transcription FactorsTranscription Factor 7-Like 1 ProteinVDJ RecombinasesDNA PrimersHomeodomain ProteinsRAG-1 proteinTcf7l1 protein, mouseTCF Transcription FactorsTranscription Factor 7-Like 1 ProteinVDJ Recombinases

Identifiers

PMID16365147
PMCPMC2212960
OpenAlexW2117618261

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.